WallStSmart
RGC

Regencell Bioscience Holdings Ltd

NASDAQ: RGC · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$28.95
-0.34% today

Updated 2026-04-29

Market cap
$14.32B
P/E ratio
P/S ratio
EPS (TTM)
$-0.01
Dividend yield
52W range
$2 – $84
Volume
0.1M

Regencell Bioscience Holdings Ltd (RGC) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+100.0%
Most recent quarter

When is the next earnings report?

Reporting date
June 30, 2025
Consensus EPS estimate
Fiscal period ending
2025-06-30

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-0.5%
Last 1 reports
Positive reaction rate
0%
0 of 1 quarters
Largest single-day move
-0.5%
2025-11-18
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2025-11-18$0.00$12.93$12.87-0.5%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-09-30$0.00$0.00
2025-06-30
2025-03-31$0.00$0.00
2024-09-30$0.00$0.00
2022-09-30$0.00$-0.30$-2.34B
2022-03-31$0.00$-0.29
2021-09-30$0.00$-0.11
2021-03-31$0.00$-33.38
2020-12-31$0.00$-0.05
2020-09-30$0.00$-0.02
2020-06-30$0.00$-0.02

Frequently asked questions

When does Regencell Bioscience Holdings Ltd report next earnings?
Regencell Bioscience Holdings Ltd (RGC) is scheduled to report earnings on June 30, 2025.
Has Regencell Bioscience Holdings Ltd beaten earnings estimates?
Regencell Bioscience Holdings Ltd has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports.
How does RGC stock react to earnings?
RGC stock has moved an average of -0.5% in the trading day following earnings over its last 1 reports, with positive reactions in 0% of those quarters.